Linda M. Mundy
Chief Medical Officer
Linda M. Mundy, MD, PhD is Vice President and Chief Medical Officer at American Regent, Inc., a Daiichi Sankyo Group Company. As a pharmaceutical executive, she leads American Regent teams with responsibilities for drug development, drug safety surveillance, medical affairs, and quantitative sciences. Prior to joining American Regent, Dr. Mundy held a position at GlaxoSmithKline focused on global antibacterial drug discovery and development.
Dr. Mundy completed her medical degree, internal medicine residency, and infectious diseases fellowship training at The Johns Hopkins University School of Medicine. She has over 250 peer-reviewed publications, book chapters, and invited lectureships.